Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: sequence and (Q43698903)
Jump to navigation
Jump to search
scientific article published in August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: sequence and |
scientific article published in August 2001 |
Statements
1 reference
Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: sequence and (English)
1 reference
1 reference
P N Münster
1 reference
A Basso
1 reference
D Solit
1 reference
N Rosen
1 reference
1 August 2001
1 reference
1 reference